IT IS good news for chimpanzees, but bad news for people with hepatitis C. The US National Institutes of Health (NIH) is likely to slash medical research on chimpanzees, and transfer most research chimps to sanctuaries. The plan is being hailed as a triumph for animal rights, but there is a snag: it could delay work on a hepatitis C vaccine.
Following a 2011 report concluding that most medical research on chimps was unnecessary, the NIH – which uses 360 of around 1000 research chimps in the US – set up an advisory committee. This body has now issued recommendations. Most of the NIH’s chimps should retire to sanctuaries, but about 50 should be retained for future research, housed in environments that promote their natural behaviour: large groups, plenty of space and lots of activities.
“It’s excellent news,” says Barbara King of the College of William and Mary in Williamsburg, Virginia. “These chimpanzees have served and suffered for us.”
But some hepatitis C researchers are less happy. Chimps are the only non-human animal that the virus infects, so are used in the development of a vaccine.
“If there is no access to a chimpanzee model, it will likely slow vaccine development and put human lives at risk,” says Stanley Lemon of the University of North Carolina at Chapel Hill.
“If there is no access to a chimpanzee model, it will slow vaccine development and put lives at risk”
This article appeared in print under the headline “US chimps retire”
More on these topics: